drugset
drugset / Trial / NCT05670743

Pharmacokinetics of Advantage Arrest in Healthy Children 13-Months to 13-Years of Age

NCT05670743 ↗

Phase 2 Completed 23 enrolled Advantage Silver Dental Arrest, LLC University of Washington · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to further characterize basic pharmacokinetic (PK) parameters in healthy children to contribute to evidence for the safety of silver diamine fluoride (SDF; Advantage Arrest). Children with at least one active cavity will be treated and then have blood draws at random time points afterwards.

Timeline

Start
2023-03-01
Primary completion
2023-06-10
Completion
2024-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject silver diammine fluoride Small molecule 38 % Topical

Indications

dental caries